Przycisk z rozwijanym menu

Data Lake and Sanofi Join Forces to Create a Rare Disease Patient Registry

Data Lake and Sanofi Join Forces to Create a Rare Disease Patient Registry graphics full Data Lake

Warsaw, June 11, 2024

Press Release

Data Lake, an innovative startup specializing in medical data management, partners with Sanofi Polska, a leader in the pharmaceutical industry. The aim of this partnership is to create the first patient registry in Poland for the rare disease ASMD (Acid Sphingomyelinase Deficiency) based on patient consent. ASMD is an ultra-rare genetic disorder characterized by the accumulation of sphingomyelin in cells, leading to damage to internal organs such as the liver, spleen, and lungs.

The registry, named PASMO (Patient Pathway ASMD Optimization), will form the basis for analyzing the diagnostic and therapeutic pathways of ASMD patients and developing AI algorithms for more effective diagnosis of the disease. Fast and efficient diagnosis of this disease is currently particularly important due to the recent availability of effective treatment in Poland.

Data Lake, as the operator of the registry, will be responsible for the technological and operational aspects of the project, while Sanofi Polska, as the project sponsor, provides financial and substantive support.

The registry is also being carried out under the patronage and with the support of patient organizations such as the National Forum for the Therapy of Rare Diseases Orphan, My Patients Foundation, Polish Patients Federation, Neurofibromatosis Association Poland, Niemann-Pick Association, the ASMD Patients and Families Association, and the Data Donation Foundation.

Key project assumptions include empowering patients through data access management technology, active participation of patient organizations at every stage of work, and independent oversight of the registry by a Scientific Council composed of eminent medical experts and clinicians. Data processing transparency will be ensured through the use of blockchain technology. The database structure will be designed from the outset with the intention of training AI algorithms. The project will be based on international Good Registry Practice guidelines such as AHRQ, PARENT, and REQUEST.

“Sanofi has been committed to improving the quality of life for patients with rare diseases for years. The partnership with Data Lake will allow us to support ASMD patients and develop new technological solutions that will have a real impact on their diagnosis and treatment,” said Dr. Joanna Lis, Market Access Director, Sanofi sp. z o.o.

“We are proud to collaborate with Sanofi on such an innovative project. The PASMO registry will not only enable a better understanding of the diagnostic and therapeutic pathways of ASMD patients in Poland but also contribute to the development of modern AI technologies in medicine. In the PASMO project, we have the ambition to showcase an innovative data access model that can be replicated in other rare diseases and internationally,” added Wojciech Sierocki, CEO of Data Lake.

Contact:

Data Lake
Email: [email protected]
Phone: +48 783 820 536

We especially encourage clinicians involved in the diagnosis and treatment of ASMD, as well as patients who would like to be included in the Registry, to get in touch with us.

About Sanofi

Sanofi is an innovative, global biopharmaceutical company with one goal: To make the impossible possible by discovering, developing and delivering medicines and vaccines to millions of people around the world, while putting sustainability and social responsibility at the heart of our ambitions. Sanofi is one of the largest pharmaceutical companies in Poland according to the national ranking IQVIA Poland. The group has a production plant in Rzeszów and a distribution center in Błonie near Warsaw. Sanofi is listed on the Paris and New York stock exchanges: EURONEXT: SAN and NASDAQ: SNY

For more information, visit the websites of Data Lake and Sanofi.

About Data Lake

Data Lake is a startup specializing in medical data management and the creation of medical registries. Utilizing blockchain technology and regulatory, research, and technological expertise, Data Lake is capable of implementing complex research projects based on real-world data (RWD).

Share:

Related Posts

From Protocol to People: Data Lake’s Community Chapter 🌊

Since day one, Data Lake has been about more than technology. It has been about trust, transparency, and empowering people to take an active role in shaping the future of science. We built the Data Lake Application on Arbitrum so that every patient consent is stored on-chain with a complete audit trail – a level of accountability rarely seen in healthcare. We launched LAKE.fun, the world’s first fully decentralized patient recruitment platform, where people around the globe can contribute to research projects and get rewarded transparently in $LAKE. We ran Snapshot votes to ensure that key decisions, like research reward pools, were made by the community. And we even launched a marketing bounty program, proving that our growth belongs to everyone, not just the core team. This foundation has always been about decentralization. About people. About you. 🔓 Open-Sourcing Our Smart Contracts We believe that true trust requires open infrastructure. That’s why we are open-sourcing our consents smart contracts under the Digital Public Good (DPG) framework. The DPG framework, developed by the UN and international partners, is a global standard that recognizes technologies which: ✅ Are open source ✅ Protect privacy ✅ Advance the UN Sustainable Development Goals ✅ Can

Read More

Data Lake Study Published in Diagnostics: Proving the Power of Data Donation

Big milestone for the Data Lake: our study has just been published in the peer-reviewed journal Diagnostics 🎉 The study — “Analyzing the Gaps in Breast Cancer Diagnostics in Poland—A Retrospective Observational Study in the Data Donation Model” — is one of the first peer-reviewed proofs of how patient-driven data donation can be used to uncover real-world healthcare challenges. 587 breast cancer cases analyzed  Patient data voluntarily donated to power the research  Key finding: while first oncology consultations were timely, delays of 3+ months emerged before surgery and treatment, revealing systemic gaps  In short: patients shared their data → researchers with the help of Data Lake mapped delays → policymakers now have evidence to fix bottlenecks.   Why It Matters for Data Lake 🌊 This is more than an academic milestone. It’s validation of the data donation model we’ve been building since day one, where we proven: Patients are willing to share their data for science, provided adequate safety and trust measures are in place. It’s possible to get access to large patient populations (20k+ data donors) working with decentralized science tools, outside of traditional academia and public research financing. Time for citizen scientists to shine! Real-world data studies can

Read More